search
Back to results

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Primary Purpose

Pressure Ulcers, Venous Ulcers, Diabetic Ulcers

Status
Completed
Phase
Not Applicable
Locations
Iceland
Study Type
Interventional
Intervention
Marigen Wound Dressing
Sponsored by
Kerecis Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pressure Ulcers focused on measuring Adult, Aged, Aged, 80 and over, Bandages, Biological Dressings, Chronic Disease, Collagen, Epithelium, Extracellular Matrix, Fibroblasts, Granulation Tissue, Humans, Leg Ulcer, Middle Aged, Prospective Studies, Soft Tissue Injuries, Treatment Outcome, Varicose Ulcer, Wound Healing, Wounds and Injuries

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Venous leg ulcer
  • Arterial leg ulcer
  • Rheumatic leg ulcer
  • Hydrostatic leg ulcer
  • Ulcer where healing is delayed because of drug therapy
  • Non-healing ulcer due to known or unknown causes

Exclusion Criteria:

  • Active infection

Sites / Locations

  • National University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Marigen Wound Dressing

Arm Description

Outcomes

Primary Outcome Measures

Wound healing

Secondary Outcome Measures

Wound granulation

Full Information

First Posted
May 4, 2011
Last Updated
February 28, 2017
Sponsor
Kerecis Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT01348581
Brief Title
Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
Official Title
Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
January 1, 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kerecis Ltd.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds. The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology. The indications for use are: partial and full-thickness wounds pressure ulcers venous ulcers diabetic ulcers chronic vascular ulcers tunneled/undermined wounds trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pressure Ulcers, Venous Ulcers, Diabetic Ulcers, Chronic Ulcer of Foot, Trauma-related Wound
Keywords
Adult, Aged, Aged, 80 and over, Bandages, Biological Dressings, Chronic Disease, Collagen, Epithelium, Extracellular Matrix, Fibroblasts, Granulation Tissue, Humans, Leg Ulcer, Middle Aged, Prospective Studies, Soft Tissue Injuries, Treatment Outcome, Varicose Ulcer, Wound Healing, Wounds and Injuries

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
37 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Marigen Wound Dressing
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Marigen Wound Dressing
Intervention Description
The dressing is changed at least twice a week, with no more than five days between dressing changes. It is extremely important that the dressings are changed sufficiently often. On highly exuding ulcers the three or four dressing changes per week may be necessary. Duration is four weeks.
Primary Outcome Measure Information:
Title
Wound healing
Time Frame
one year
Secondary Outcome Measure Information:
Title
Wound granulation
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Venous leg ulcer Arterial leg ulcer Rheumatic leg ulcer Hydrostatic leg ulcer Ulcer where healing is delayed because of drug therapy Non-healing ulcer due to known or unknown causes Exclusion Criteria: Active infection
Facility Information:
Facility Name
National University Hospital
City
Reykjavik
ZIP/Postal Code
108
Country
Iceland

12. IPD Sharing Statement

Learn more about this trial

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

We'll reach out to this number within 24 hrs